Back to FRANKLIN TEMPLETON INC FRANKLIN TEMPLETON INC

CTNMCTNM
Showing 8 of 9 quarters

Position history for FRANKLIN TEMPLETON INCFRANKLIN TEMPLETON INC's holdings in CONTINEUM THERAPEUTICS INC

Yes. Franklin Templeton holds 1,839,227 shares of CTNM (Contineum Therapeutics), worth $30.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Franklin Templeton has held CTNM in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$30.1M

Current Shares

1.8M

Total Value Change

+$6.5M

Total Shares Change

+391,677

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.8M
0.0%
$30.1M0.0%$16.39
0
2026-Q1
Decreased
1.8M
-2.1%
$24M0.0%$14.10
0
2025-Q4
Increased
1.9M
+13.5%
$21.5M0.0%$11.40
32
2025-Q3
Decreased
1.7M
-2.5%
$19.5M0.0%$11.82
0
2025-Q2
Increased
1.7M
+7.8%
$6.7M0.0%$4.11
29
2025-Q1
Increased
1.6M
+9.0%
$11M0.0%$7.07
30
2024-Q4
Decreased
1.4M
-0.1%
$21.2M0.0%$14.47
0
2024-Q3
Increased
1.4M
+130.9%
$23.6M0.0%$18.84
46

Other major holders of CTNM: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used